Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods

BackgroundExacerbations of chronic obstructive pulmonary disease (COPD), characterized by acute deterioration in symptoms, may be due to bacterial or viral infections, environmental exposures, or unknown factors. Exacerbation frequency may be a stable trait in COPD patients, which could imply genetic susceptibility. Observing the genes, networks, and pathways that are up- and down-regulated in COPD patients with differing susceptibility to exacerbations will help to elucidate the molecular signature and pathogenesis of COPD exacerbations.MethodsGene expression array and plasma biomarker data were obtained using whole-blood samples from subjects enrolled in the Treatment of Emphysema With a Gamma-Selective Retinoid Agonist (TESRA) study. Linear regression, weighted gene co-expression network analysis (WGCNA), and pathway analysis were used to identify signatures and network sub-modules associated with the number of exacerbations within the previous year; other COPD-related phenotypes were also investigated.ResultsIndividual genes were not found to be significantly associated with the number of exacerbations. However using network methods, a statistically significant gene module was identified, along with other modules showing moderate association. A diverse signature was observed across these modules using pathway analysis, marked by differences in B cell and NK cell activity, as well as cellular markers of viral infection. Within two modules, gene set enrichment analysis recapitulated the molecular signatures of two gene expression experiments; one involving sputum from asthma exacerbations and another involving viral lung infections. The plasma biomarker myeloperoxidase (MPO) was associated with the number of recent exacerbations.ConclusionA distinct signature of COPD exacerbations may be observed in peripheral blood months following the acute illness. While not predictive in this cross-sectional analysis, these results will be useful in uncovering the molecular pathogenesis of COPD exacerbations.

[1]  Tom C. Freeman,et al.  Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation , 2014, Immunity.

[2]  P. Jones,et al.  TESRA (Treatment Of Emphysema With A Selective Retinoid Agonist) Study Results , 2011, ATS 2011.

[3]  Steve Horvath,et al.  Adipose Co-expression networks across Finns and Mexicans identify novel triglyceride-associated genes , 2012, BMC Medical Genomics.

[4]  Edwin K Silverman,et al.  Network medicine approaches to the genetics of complex diseases. , 2012, Discovery medicine.

[5]  W. Kibbe,et al.  A collection of bioconductor methods to visualize gene-list annotations , 2010, BMC Research Notes.

[6]  George C Tseng,et al.  Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis , 2013, Science Translational Medicine.

[7]  R. Stockley,et al.  Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD , 2001, Thorax.

[8]  Michael Dymond,et al.  Differential gene expression analysis in human monocyte-derived macrophages: impact of cigarette smoke on host defence. , 2010, Molecular immunology.

[9]  M. Rinaldi,et al.  Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[11]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[12]  T. Nishioka.  Division of Biomedical Informatics , 2009 .

[13]  O. Ramilo,et al.  Plasticity and Virus Specificity of the Airway Epithelial Cell Immune Response during Respiratory Virus Infection , 2012, Journal of Virology.

[14]  Ivana V. Yang,et al.  The Peripheral Blood Transcriptome Identifies the Presence and Extent of Disease in Idiopathic Pulmonary Fibrosis , 2012, PloS one.

[15]  Donavan T. Cheng,et al.  Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity , 2012, PloS one.

[16]  Laszlo Nagy,et al.  Chronic Obstructive Pulmonary Disease-Specific Gene Expression Signatures of Alveolar Macrophages as well as Peripheral Blood Monocytes Overlap and Correlate with Lung Function , 2011, Respiration.

[17]  S. Atiş,et al.  Relationship between airway colonization, inflammation and exacerbation frequency in COPD. , 2007, Respiratory medicine.

[18]  Anthony Bosco,et al.  Decreased activation of inflammatory networks during acute asthma exacerbations is associated with chronic airflow obstruction , 2010, Mucosal Immunology.

[19]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[20]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Johnston,et al.  Pathophysiology of viral-induced exacerbations of COPD , 2007, International journal of chronic obstructive pulmonary disease.

[22]  H. Rehrauer,et al.  Chronic exposure to cigarette smoke condensate in vitro induces epithelial to mesenchymal transition-like changes in human bronchial epithelial cells, BEAS-2B. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[23]  S. Hodge,et al.  Enhanced cytotoxic function of natural killer and natural killer T‐like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway , 2013, Respirology.

[24]  Donavan T. Cheng,et al.  Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[25]  Rafael A Irizarry,et al.  Oligonucleotide-microarray analysis of peripheral-blood lymphocytes in severe asthma. , 2005, The Journal of laboratory and clinical medicine.

[26]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[27]  Steven Shapiro,et al.  Peripheral blood gene expression profiles in COPD subjects , 2011, Journal of Clinical Bioinformatics.

[28]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[29]  Nichole Reisdorph,et al.  Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease. , 2013, American journal of respiratory cell and molecular biology.

[30]  S. Horvath.  Weighted Network Analysis: Applications in Genomics and Systems Biology , 2011 .

[31]  E. Silverman,et al.  Clinical determinants of exacerbations in severe, early-onset COPD , 2007, European Respiratory Journal.

[32]  Gary D Bader,et al.  Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.

[33]  E. Silverman,et al.  Polymorphic variation in surfactant protein B is associated with COPD exacerbations , 2008, European Respiratory Journal.

[34]  M. Emi,et al.  A single nucleotide polymorphism in the CCL1 gene predicts acute exacerbations in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[35]  Steve Horvath,et al.  Weighted Network Analysis , 2011 .